{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:49:15Z","timestamp":1790182155285,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Major depressive disorder (MDD) is a common and debilitating mental illness characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily activities. The objective of this study was to investigate whether levels of macrophage inflammatory protein-1\u03b2 (MIP-1\u03b2) and macrophage chemoattractant protein-2 (MCP-2) in the blood were associated with the pathophysiology and development of MDD compared to healthy controls (HCs).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This case-control study was conducted involving 50 MDD patients and 38 HCs. We performed a comprehensive assessment to match age, sex, BMI, and socio-demographic profile between the groups. The study excluded participants with chronic infection, inflammatory diseases, coexisting psychiatric disorder, history of liver and kidney diseases, and individuals who are under antipsychotic medications. A professional psychiatrist diagnosed MDD patients and evaluated HCs based on the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria. The severity of depression was assessed using the Hamilton Depression (Ham-D) rating scale. Commercially available enzyme-linked immunosorbent assay (ELISA) kits were used to quantify the serum MIP-1\u03b2 and MCP-2 levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The results indicated elevated serum MIP-1\u03b2 levels (207.73\u00b124.24 pg\/ml) in MDD patients compared to HCs (58.77\u00b19.14 pg\/ml). This difference in concentration is positively correlated with severity of disease symptoms (r = 0.451; p&lt;0.001). Similarly, the levels of MCP-2 were found to be elevated in patients compared to controls (143.61\u00b119.92 vs. 56.84\u00b14.02 pg\/ml; p = 0.003), with a positive correlation with the Ham-D scores (r = 0.373; p = 0.004).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>According to this study, elevated levels of MIP-1\u03b2 and MCP-2 may be associated with the pathophysiology and development of MDD. These increased serum MIP-1\u03b2 and MCP-2 levels could be used as risk assessment tools for MDD. The present findings urge further research and the development of therapeutic and diagnostic approaches for depression.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0305734","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:27:10Z","timestamp":1718731630000},"page":"e0305734","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of serum MIP-1\u03b2 and MCP-2 levels in major depressive disorder: A case-control study"],"prefix":"10.1371","volume":"19","author":[{"given":"Mariya","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S. M.","family":"Roknuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahriar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Mohammad Ashraful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2218-4061","authenticated-orcid":true,"given":"Mohiuddin","family":"Ahmed Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. A. Shalahuddin","family":"Qusar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Rahman","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-3144","authenticated-orcid":true,"given":"Rabiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"pone.0305734.ref001","author":"Depressive disorder (depression).","year":"2023","journal-title":"World Health Organization."},{"key":"pone.0305734.ref002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/epirev\/mxh001","article-title":"Socioeconomic position and major mental disorders.","volume":"26","author":"C Muntaner","year":"2004","journal-title":"Epidemiol Rev"},{"issue":"1","key":"pone.0305734.ref003","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41598-024-51932-9","article-title":"Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder.","volume":"14","author":"N Sarmin","year":"2024","journal-title":"Sci Rep."},{"issue":"1","key":"pone.0305734.ref004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12888-023-05463-8","article-title":"Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative design.","volume":"24","author":"Z Nahar","year":"2024","journal-title":"BMC Psychiatry."},{"key":"pone.0305734.ref005","doi-asserted-by":"crossref","first-page":"2632010X231220841","DOI":"10.1177\/2632010X231220841","article-title":"Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder.","volume":"16","author":"KF Supti","year":"2023","journal-title":"Clin Pathol."},{"issue":"11","key":"pone.0305734.ref006","doi-asserted-by":"crossref","first-page":"e0294288","DOI":"10.1371\/journal.pone.0294288","article-title":"Altered serum TNF-\u03b1 and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.","volume":"18","author":"J Nayem","year":"2023","journal-title":"PLoS One."},{"issue":"1","key":"pone.0305734.ref007","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12888-023-05354-y","article-title":"Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study.","volume":"23","author":"MS Akter","year":"2023","journal-title":"BMC Psychiatry."},{"issue":"7","key":"pone.0305734.ref008","doi-asserted-by":"crossref","first-page":"e0288159","DOI":"10.1371\/journal.pone.0288159","article-title":"Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study.","volume":"18","author":"M Sohan","year":"2023","journal-title":"PLoS One."},{"key":"pone.0305734.ref009","doi-asserted-by":"crossref","first-page":"2632010X231180797","DOI":"10.1177\/2632010X231180797","article-title":"Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study.","volume":"16","author":"FI Suhee","year":"2023","journal-title":"Clin Pathol."},{"key":"pone.0305734.ref010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2022.01.103","article-title":"Predictors of suicidal ideation, suicide attempt and suicide death among people with major depressive disorder: A systematic review and meta-analysis of cohort studies","volume":"302","author":"X Li","year":"2022","journal-title":"J Affect Disord"},{"issue":"3","key":"pone.0305734.ref011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management.","volume":"22","author":"M Berk","year":"2023","journal-title":"World Psychiatry"},{"issue":"1","key":"pone.0305734.ref012","doi-asserted-by":"crossref","first-page":"18976","DOI":"10.1038\/s41598-023-46401-8","article-title":"Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive-compulsive disorder: a case-control study findings.","volume":"13","author":"R Sarker","year":"2023","journal-title":"Sci Rep."},{"issue":"1","key":"pone.0305734.ref013","first-page":"e3868","article-title":"Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-na\u00efve Major Depressive Disorder Patients.","volume":"11","author":"NL Nishuty","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"pone.0305734.ref014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12888-018-1685-z","article-title":"Alterations of serum macro-minerals and trace elements are associated with major depressive disorder: a case-control study.","volume":"18","author":"MR Islam","year":"2018","journal-title":"BMC Psychiatry."},{"key":"pone.0305734.ref015","doi-asserted-by":"crossref","first-page":"2050312118773953","DOI":"10.1177\/2050312118773953","article-title":"Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study.","volume":"6","author":"MR Islam","year":"2018","journal-title":"SAGE Open Med."},{"key":"pone.0305734.ref016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12688\/f1000research.9736.1","article-title":"Serotonin receptors in depression: from A to B.","volume":"6","author":"KM Nautiyal","year":"2017","journal-title":"F1000Res."},{"issue":"4","key":"pone.0305734.ref017","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.biopsych.2004.11.017","article-title":"Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression","volume":"57","author":"A Pfennig","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"pone.0305734.ref018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2009.12.011","article-title":"The cortisol awakening response: more than a measure of HPA axis function.","volume":"35","author":"A Clow","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"pone.0305734.ref019","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11920-011-0251-x","article-title":"Gene-environment interaction in major depression and antidepressant treatment response.","volume":"14","author":"R Keers","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"pone.0305734.ref020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2021.04.003","article-title":"A systematic review of the association between biological markers and environmental stress risk factors for adolescent depression","volume":"138","author":"Z Zajkowska","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"1","key":"pone.0305734.ref021","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: A review","volume":"53","author":"R Troubat","year":"2021","journal-title":"Eur J Neurosci"},{"key":"pone.0305734.ref022","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pnpbp.2013.10.018","article-title":"Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants","volume":"48","author":"BE Leonard","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"pone.0305734.ref023","first-page":"e6081","article-title":"Evaluation of Serum Glial Cell Line-derived Neurotrophic Factor in Bangladeshi Major Depressive Disorder Patients.","volume":"11","author":"R Das","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"pone.0305734.ref024","first-page":"83","article-title":"Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy","volume":"13","author":"MPZ Emon","year":"2020","journal-title":"Published 2020 Feb 21"},{"issue":"11","key":"pone.0305734.ref025","doi-asserted-by":"crossref","first-page":"e0276619","DOI":"10.1371\/journal.pone.0276619","article-title":"Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study.","volume":"17","author":"S Islam","year":"2022","journal-title":"PLoS One."},{"issue":"1","key":"pone.0305734.ref026","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/mp.2017.205","article-title":"Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis","volume":"23","author":"SP Leighton","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"9","key":"pone.0305734.ref027","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.psyneuen.2012.03.019","article-title":"Neuroplastic changes in depression: a role for the immune system.","volume":"37","author":"H Eyre","year":"2012","journal-title":"Psychoneuroendocrinology."},{"issue":"3","key":"pone.0305734.ref028","doi-asserted-by":"crossref","first-page":"151911","DOI":"10.1016\/j.imbio.2020.151911","article-title":"Changes in macrophage inflammatory protein-1 (MIP-1) family members expression induced by traumatic brain injury in mice.","volume":"225","author":"A Ciechanowska","year":"2020","journal-title":"Immunobiology"},{"key":"pone.0305734.ref029","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.2147\/PRBM.S384267","article-title":"Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder.","volume":"15","author":"W Gao","year":"2022","journal-title":"Psychol Res Behav Manag."},{"issue":"6","key":"pone.0305734.ref030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.pharep.2018.06.001","article-title":"The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1\u03b2) and depression with and without posttraumatic stress disorder.","volume":"70","author":"EA Og\u0142odek","year":"2018","journal-title":"Pharmacol Rep"},{"issue":"2","key":"pone.0305734.ref031","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder.","volume":"35","author":"SM Lehto","year":"2010","journal-title":"Psychoneuroendocrinology."},{"key":"pone.0305734.ref032","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.2147\/PRBM.S384267","article-title":"Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder.","volume":"15","author":"W Gao","year":"2022","journal-title":"Psychol Res Behav Manag."},{"issue":"21\u201322","key":"pone.0305734.ref033","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.cca.2010.07.006","article-title":"MCP-1: chemoattractant with a role beyond immunity: a review","volume":"411","author":"A Yadav","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"3","key":"pone.0305734.ref034","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/13811118.2019.1649772","article-title":"MCP-2\/CCL8 Level Associated With Suicidal Ideation in Elderly Men With Major Depression.","volume":"24","author":"MN Liu","year":"2020","journal-title":"Arch Suicide Res."},{"issue":"2","key":"pone.0305734.ref035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcv.2014.03.004","article-title":"Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation","volume":"60","author":"T Pawlowski","year":"2014","journal-title":"J Clin Virol"},{"key":"pone.0305734.ref036","doi-asserted-by":"crossref","first-page":"3946320231198828","DOI":"10.1177\/03946320231198828","article-title":"Evaluation of inflammatory cytokines in drug-na\u00efve major depressive disorder: A systematic review and meta-analysis.","volume":"37","author":"MR Islam","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"pone.0305734.ref037","doi-asserted-by":"crossref","first-page":"e1005","DOI":"10.1002\/hsr2.1005","article-title":"Higher serum interleukin-12 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.","volume":"6","author":"Z Nahar","year":"2022","journal-title":"Health Sci Rep."},{"key":"pone.0305734.ref038","doi-asserted-by":"crossref","first-page":"113568","DOI":"10.1016\/j.psychres.2020.113568","article-title":"Higher levels of serum IL-1\u03b2 and TNF-\u03b1 are associated with an increased probability of major depressive disorder.","volume":"295","author":"R Das","year":"2021","journal-title":"Psychiatry Res"},{"key":"pone.0305734.ref039","doi-asserted-by":"crossref","first-page":"2050312120974169","DOI":"10.1177\/2050312120974169","article-title":"Serum interferon-gamma level is associated with drug-na\u00efve major depressive disorder.","volume":"8","author":"S Daria","year":"2020","journal-title":"SAGE Open Med."},{"issue":"2","key":"pone.0305734.ref040","doi-asserted-by":"crossref","first-page":"e0264404","DOI":"10.1371\/journal.pone.0264404","article-title":"Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study.","volume":"17","author":"S Rahman","year":"2022","journal-title":"PLoS One."},{"issue":"4","key":"pone.0305734.ref041","doi-asserted-by":"crossref","first-page":"3000605231166222","DOI":"10.1177\/03000605231166222","article-title":"Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case-control study","volume":"51","author":"L Salsabil","year":"2023","journal-title":"J Int Med Res"},{"issue":"1","key":"pone.0305734.ref042","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-5728(98)00002-2","article-title":"MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study","volume":"86","author":"C McManus","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"4","key":"pone.0305734.ref043","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1165\/ajrcmb.21.4.3660","article-title":"Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines","volume":"21","author":"JL Pype","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"25","key":"pone.0305734.ref044","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1073\/pnas.240469997","article-title":"Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.","volume":"97","author":"F Cocchi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pone.0305734.ref045","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1128\/IAI.68.12.6917-6923.2000","article-title":"Gene expression and production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), IL-8, macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles.","volume":"68","author":"JA Lapinet","year":"2000","journal-title":"Infect Immun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:27:45Z","timestamp":1718731665000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305734"}},"subtitle":[],"editor":[{"given":"Prasenjit","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0305734","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}